| Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters K McMahan, V Giffin, LH Tostanoski, B Chung, M Siamatu, MS Suthar, ... Med 3 (4), 262-268. e4, 2022 | 173 | 2022 |
| CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques J Liu, J Yu, K McMahan, C Jacob-Dolan, X He, V Giffin, C Wu, M Sciacca, ... Science immunology 7 (77), eabq7647, 2022 | 91 | 2022 |
| Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine MS Gebre, S Rauch, N Roth, J Yu, A Chandrashekar, NB Mercado, X He, ... Nature 601 (7893), 410-414, 2022 | 87 | 2022 |
| Protective efficacy of Ad26. COV2. S against SARS-CoV-2 B. 1.351 in macaques J Yu, LH Tostanoski, NB Mercado, K McMahan, J Liu, C Jacob-Dolan, ... Nature 596 (7872), 423-427, 2021 | 46 | 2021 |
| Immunity elicited by natural infection or Ad26. COV2. S vaccination protects hamsters against SARS-CoV-2 variants of concern LH Tostanoski, J Yu, NB Mercado, K McMahan, C Jacob-Dolan, ... Science translational medicine 13 (618), eabj3789, 2021 | 33 | 2021 |
| SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques NC Dalvie, LH Tostanoski, SA Rodriguez-Aponte, K Kaur, S Bajoria, ... Science advances 8 (11), eabl6015, 2022 | 29 | 2022 |
| Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B. 1.1. 7 and B. 1.351 variants A Chandrashekar, J Liu, J Yu, K McMahan, LH Tostanoski, ... Science translational medicine 13 (618), eabj2641, 2021 | 16 | 2021 |
| A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates NC Dalvie, LH Tostanoski, SA Rodriguez-Aponte, K Kaur, S Bajoria, ... bioRxiv, 2021 | 13 | 2021 |
| CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques. Sci. Immunol. 7, eabq7647 J Liu, J Yu, K McMahan, C Jacob-Dolan, X He, V Giffin, C Wu, M Sciacca, ... | 9 | 2022 |
| Reduced pathogenicity of the SARS-CoV-2 Omicron variant in hamsters. bioRxiv 2022 K McMahan, V Giffin, L Tostanoski, B Chung, M Siamatu, M Suthar, ... Preprint]. doi 2002, 2022 | 9 | 2022 |
| Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques C Jacob-Dolan, J Yu, K McMahan, V Giffin, A Chandrashekar, AJ Martinot, ... npj Vaccines 8 (1), 23, 2023 | 8 | 2023 |
| Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters. Med (NY) 3: 262-268. e4 K McMahan, V Giffin, LH Tostanoski, B Chung, M Siamatu, MS Suthar, ... | 7 | 2022 |
| Optimization of non-coding regions improves protective efficacy of an mRNA SARS-CoV-2 vaccine in nonhuman primates MS Gebre, S Rauch, N Roth, J Yu, A Chandrashekar, NB Mercado, X He, ... BioRxiv, 2021.08. 13.456316, 2021 | 7 | 2021 |
| Protective efficacy of gastrointestinal SARS-CoV-2 delivery against intranasal and intratracheal SARS-CoV-2 challenge in rhesus macaques J Yu, ND Collins, NB Mercado, K McMahan, A Chandrashekar, J Liu, ... Journal of virology 96 (2), e01599-21, 2022 | 5 | 2022 |
| Reduced pathogenicity of the SARS-CoV-2 Omicron variant in hamsters. Med. 2022; 3: 262–268. e4 K McMahan, V Giffin, LH Tostanoski, B Chung, M Siamatu, MS Suthar, ... | 5 | |
| Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques JD Ventura, JP Nkolola, A Chandrashekar, EN Borducchi, J Liu, ... npj Vaccines 7 (1), 53, 2022 | 4 | 2022 |
| Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessments C Piedra-Mora, SR Robinson, LH Tostanoski, DAE Dayao, ... Veterinary Pathology 59 (4), 648-660, 2022 | 2 | 2022 |
| Abstract B004: Neoantigen adenoviral cancer vaccine generates improved CD8+ T-cell responses compared to adjuvanted peptide vaccine G Dagotto, A Colarusso, R Patio, D Li, T Anioke, V Giffin, M Aid, ... Cancer Immunology Research 11 (12_Supplement), B004-B004, 2023 | | 2023 |
| A genetically engineered, stem-cell-derived cellular vaccine A Cooper, A Sidaway, A Chandrashekar, E Latta, K Chakraborty, J Yu, ... Cell Reports Medicine 3 (12), 2022 | | 2022 |
| A Novel CRISPR-Engineered, Stem Cell-Derived Cellular Vaccine K Chakraborty, A Chandrashekar, A Sidaway, E Latta, J Yu, K McMahan, ... bioRxiv, 2021.12. 28.474336, 2021 | | 2021 |
